BioSpace News Archive

FDA

WuXi Biologics Successfully Completed First FDA Routine GMP Inspection

FDA typically conducts this inspection every two years upon product approval.

April 17, 2019
·
2 min read
Biotech Beach

Laguna Treatment Hospital Hosts Community Event on Underage Drinking

‘From Underage Drinking to Addiction: Stories and Stats We Can’t Ignore’ will also feature a former “Baywatch” TV star whose addiction started as a teenager with alcohol

April 17, 2019
·
2 min read
Business

Amgen Foundation Launches Amgen Biotech Experience In Tampa, Florida

The Amgen Foundation, together with the University of South Florida (USF), today announced the launch of the Amgen Biotech Experience (ABE) program in Tampa, Florida, as part of its long-standing science education program.

April 17, 2019
·
4 min read
Business

Pennsylvania Dental Association Installs Dr. Charles Incalcaterra as President

The Pennsylvania Dental Association (PDA) recently installed Dr. Charles Incalcaterra of Orefield, Lehigh County, as its 2019-2020 President, at its annual meeting in Gettysburg.

April 17, 2019
·
1 min read
Business

SK Biopharmaceuticals and twoXAR Sign Collaboration Agreement to Discover and Develop First-In-Class Treatments for Non-Small Cell Lung Cancer

SK Biopharmaceuticals and twoXAR, Inc. announced an agreement to discover and develop first-in-class therapeutics for non-small cell lung cancer.

April 17, 2019
·
4 min read
BioForest

Declining Healthcare Affordability for Medically Underserved Populations is Traceable to Revenue-Maximizing Policy Decisions by 340B Hospitals & Pharmacies

It is less likely that a person in poverty and without year-round health insurance is able to afford needed prescription drugs than a similarly situated person ten years ago.

April 17, 2019
·
2 min read
Deals

Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock - April 17, 2019

Eiger BioPharmaceuticals, Inc. announced the pricing of an underwritten public offering of 4,500,000 shares of its common stock at a price to the public of $11.00 per share.

April 17, 2019
·
4 min read
Deals

Kiadis to Acquire CytoSen Therapeutics, Inc.

Transaction creates leader in cell-based cancer immunotherapy, with complementary T-cell and NK-cell platforms focused initially on hematopoietic stem cell transplants (HSCT)

April 17, 2019
·
11 min read
Pharm Country

Jackson ImmunoResearch launches Secondary Antibodies for VHH discovery

Anti-Alpaca IgG, Subclass and VHH domain secondary antibodies to optimize VHH (single-domain) antibody development and application

April 17, 2019
·
1 min read
QuantuMDx Group Ltd has announced plans to expand the potential of its Q-POC™ technology and develop a quality control analytics system for cell and gene therapies (“C>”s), to be evaluated by GlaxoSmithKline’s C> platform group

Within this context, the ability to provide rapid throughput, lab-standard and decentralised safety testing and analytics, on a batch by batch basis, could offer considerable benefits.

April 17, 2019
·
2 min read